共 50 条
CSF-1/CSF-1R targeting agents in clinical development for cancer therapy
被引:112
作者:
Ries, Carola H.
[1
]
Hoves, Sabine
[1
]
Cannarile, Michael A.
[1
]
Ruettinger, Dominik
[1
]
机构:
[1] Roche Innovat Ctr Penzberg, Roche Pharmaceut Res & Early Dev, Nonnenwald 2, D-82377 Penzberg, Germany
关键词:
TUMOR-ASSOCIATED MACROPHAGES;
INFILTRATING MYELOID CELLS;
KINASE INHIBITOR;
GENETIC PROGRAMS;
C-FMS;
IMPROVES;
POLARIZATION;
EFFICACY;
ANTIBODY;
REVEALS;
D O I:
10.1016/j.coph.2015.05.008
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
Macrophage infiltration has been identified as an independent poor prognostic factor for several cancer entities. In mouse tumor models macrophages orchestrate various tumor-promoting processes. This observation sparked an interest to therapeutically target these plastic innate immune cells. To date, blockade of colony stimulating factor-1 or its receptor represents the only truly selective approach to manipulate macrophages in cancer patients. Here, we discuss the currently available information on efficacy and safety of various CSF-1/CSF-1R inhibitors in cancer patients and highlight potential combination partners emerging from preclinical studies while considering the differences between mouse and human macrophage biology.
引用
收藏
页码:45 / 51
页数:7
相关论文
共 50 条